(Q37650317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

15 January 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jörg Janne Vehreschild

series ordinal

1

object named as

Jörg J Vehreschild

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

Maria J G T Rüping

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

Angela Steinbach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

95-113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

The changing face of epidemiology of invasive fungal disease in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Cryptococcosis in solid organ transplant recipients: current state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Managing cryptococcosis in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Current epidemiology of Pneumocystis pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Infection in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology of fungal infections in solid organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Candidemia in Norway (1991 to 2003): results from a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive Candida species infections: a 5 year population-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Candidemia in Finland, 1995-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prophylaxis and treatment of invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Mycoses in the transplanted patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Impact of donor infections on outcome of orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Preemptive treatment of fungal infection based on plasma (1 --> 3)beta-D-glucan levels after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Aspergillus PCR formidable challenges and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Antifungal prophylaxis for invasive mycoses in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Variation in antifungal prophylaxis strategies in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Antifungal management practices in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Voriconazole versus liposomal amphotericin B for empirical antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Empirical antifungal therapy--new options, new tradeoffs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Combination antifungal therapy: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903405639

10.1517/14656560903405639

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001432%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference